| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/29/1993 | WO1993007875A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121901A1 Contrast agents and compositions for radiological imaging, and radiological imaging method utilizing same |
| 04/29/1993 | CA2121838A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 04/29/1993 | CA2121582A1 An improved drugscreening method |
| 04/29/1993 | CA2120130A1 Treated apatite particles for medical diagnostic imaging |
| 04/28/1993 | EP0538373A1 Anti-herpes virus and cytomegalovirus oligomers |
| 04/27/1993 | US5205917 Fluorophore assisted carbohydrate electrophoresis diagnosis |
| 04/27/1993 | US5205290 Kits for imaging gastrointestinal disorders; anti-gas; biocompatible polymers, thickeners |
| 04/27/1993 | US5205287 Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents |
| 04/21/1993 | EP0537276A1 Cancer-associated scm-recognition factor, preparation and method of use |
| 04/20/1993 | US5204457 Used in nuclear magnetic resonance imaging; forming carboxy-alkylether of a polysaccharide and complexing with magnetic metal oxide |
| 04/20/1993 | US5204086 X-ray contrast agent |
| 04/20/1993 | US5204085 Adding calcium salts |
| 04/20/1993 | US5203338 Vascular catheter having low-profile distal end |
| 04/20/1993 | US5203332 Magnetic resonance imaging |
| 04/15/1993 | WO1993007293A1 Detecting digeorge syndrome mutations |
| 04/15/1993 | WO1993006869A1 Gaseous ultrasound contrast agents |
| 04/15/1993 | WO1993006868A1 Dendrimeric polychelants |
| 04/15/1993 | WO1993006835A1 Leukocyte adhesion molecule-1 (lam-1) and ligand thereof |
| 04/15/1993 | CA2120763A1 Dendrimeric polychelants |
| 04/14/1993 | EP0536838A2 Non-A, non-B peptides |
| 04/08/1993 | CA2079439A1 Non-a, non-b peptides |
| 04/07/1993 | EP0535898A1 Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| 04/07/1993 | EP0535668A1 Imaging agent for diagnosis |
| 04/07/1993 | EP0535534A1 Biocompatible emulsion particles |
| 04/07/1993 | EP0535387A1 Echographique particle, preparation and application |
| 04/06/1993 | US5200430 Debridement of bodily cavities using debridement fluids |
| 04/06/1993 | CA1315778C Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 04/03/1993 | CA2078388A1 Biocompatible emulsion particles |
| 04/03/1993 | CA2065662A1 In vivo cancer treatment assay |
| 04/01/1993 | WO1993006231A1 Anti-human milk fat globule humanised antibodies |
| 04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
| 04/01/1993 | WO1993006148A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 04/01/1993 | WO1993005820A1 Purification of crude ioversol using continuous deionization |
| 04/01/1993 | WO1993005819A1 Gaseous ultrasound contrast media and method for selecting gases for use as ultrasound contrast media |
| 04/01/1993 | WO1993005818A1 Diagnostic agents |
| 04/01/1993 | WO1993005815A1 Synthetic transfection vectors |
| 04/01/1993 | WO1993005794A1 Preservative for pharmaceutical products |
| 04/01/1993 | WO1992022583A3 Tri- and tetra-valent monospecific antigen-binding proteins |
| 04/01/1993 | CA2119444A1 Preservative for pharmaceutical products |
| 04/01/1993 | CA2116675A1 Diagnostic agents |
| 04/01/1993 | CA2116357A1 Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications |
| 04/01/1993 | CA2116223A1 Purification of crude ioversol using continuous deionization |
| 03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
| 03/31/1993 | EP0533898A1 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 03/31/1993 | EP0533886A1 Preparation of diagnostic agents |
| 03/31/1993 | EP0533845A1 USING 5,10,15,20-TETRAKIS(r-CARBOXYPHENYL)PORPHINE FOR DETECTING AND TREATING LUNG CANCER |
| 03/31/1993 | EP0467885A4 Native-state method and system for determining viability and proliferative capacity of tissues -i(in vitro) |
| 03/31/1993 | EP0374266B1 Solid x-ray contrast medium |
| 03/30/1993 | US5198208 Aminopolycarboxylic acids and derivatives thereof |
| 03/23/1993 | US5196576 Chelating compounds and their use |
| 03/23/1993 | US5196348 Perfluoro-crown ethers in fluorine magnetic resonance spectroscopy of biopsied tissue |
| 03/23/1993 | US5196199 Hydrophilic form of perfluoro compounds and method of manufacture |
| 03/23/1993 | US5196183 Fatty acid cores encapsulated with human serum albumin |
| 03/23/1993 | US5195520 Ultrasonic manometry process in a fluid by means of microbubbles |
| 03/18/1993 | WO1993005088A1 Catalysts which stabilize hydrohalocarbon blowing agent in polyurethane foam formulations |
| 03/18/1993 | WO1993004712A1 Medicated syringe preparation |
| 03/18/1993 | WO1993002710A3 Use of persistent free radicals in magnetic resonance imaging |
| 03/18/1993 | WO1993001272A3 Bioassay method |
| 03/17/1993 | EP0531472A1 Humanized and chimeric monoclonal antibodies |
| 03/17/1993 | EP0531421A1 Contrast media for ultrasonic imaging |
| 03/17/1993 | EP0531365A1 Diagnosis and treatment of viral hepatitis |
| 03/16/1993 | US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity |
| 03/16/1993 | US5194245 By comparing the level of oligoadenylate synthetase in an infected and healthy individual |
| 03/16/1993 | CA1314478C Iodine-containing emulsion |
| 03/10/1993 | EP0530343A1 Water soluble, non-ionic x-ray contrasting agents and process for producing the same. |
| 03/10/1993 | EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof |
| 03/10/1993 | EP0525181A4 Novel lanthanide chelate-conjugated oligonucleotides |
| 03/10/1993 | EP0406363B1 Method to diagnose amyloidoses specifically and substance therefor |
| 03/10/1993 | EP0214975B1 Process for the determination of small quantities of drugs, body substances or other chemical substances in a biological material |
| 03/09/1993 | US5192549 Ammonium gradient, sustained release, doxorubicin, acridine orange |
| 03/04/1993 | WO1993004194A1 LABELLED β-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 03/04/1993 | WO1993003771A1 Fullerene compositions for magnetic resonance spectroscopy and imaging |
| 03/04/1993 | WO1993003671A1 Method of mri imaging using diamagnetic contrast agents |
| 03/04/1993 | CA2115582A1 Method of mri imaging using diamagnetic contrast agents |
| 03/04/1993 | CA2113996A1 Fullerene compositions for magnetic resonance spectroscopy and imaging |
| 03/04/1993 | CA2077383A1 Echogenic particles, a process for their production and their use |
| 03/03/1993 | EP0529175A1 Conjugates chelated with paramagnetic metals for targetting |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0528804A1 Method for the study of internal body tissues |
| 03/02/1993 | US5191120 Process for preparing nonionic X-ray contrast agents |
| 03/02/1993 | US5191119 Process for producing non-ionic radiographic contrast media utilizing N-allylation |
| 03/02/1993 | US5190858 Bonding tissues |
| 03/02/1993 | US5190766 Administering anticancer drugs to specific locations in human bodies |
| 03/02/1993 | US5190744 Methods for detecting blood perfusion variations by magnetic resonance imaging |
| 03/02/1993 | US5190743 Composition for disclosing dental plaque |
| 03/02/1993 | US5190741 Aminopropyl Radioactive Iodobenzamides |
| 03/02/1993 | CA1314042C Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
| 02/24/1993 | EP0526503A4 Polymers as contrast media for magnetic resonance imaging |
| 02/23/1993 | US5188816 Using polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS |
| 02/18/1993 | WO1993003351A1 Amino acid, ester and/or catechol contrast agents for mri |
| 02/18/1993 | WO1993002713A1 Heavy metal clusters for use as imaging agents |
| 02/18/1993 | WO1993002712A1 Preparation of microparticles |
| 02/18/1993 | WO1993002711A1 Use of persistent free-radicals in magnetic resonance imaging |
| 02/18/1993 | WO1993002710A2 Use of persistent free radicals in magnetic resonance imaging |
| 02/18/1993 | DE4127442A1 Aq. dispersion of phospholipid(s) contg. fluorocarbon(s) - used as gas transporting media in diagnoses, and as an oxygen@ transporting substance e.g. a component of artificial blood |
| 02/18/1993 | CA2115275A1 Amino acid, ester and/or catechol contrast agents for mri |
| 02/18/1993 | CA2115260A1 Use of persistent free-radicals in magnetic resonance imaging |
| 02/18/1993 | CA2113997A1 Heavy metal clusters for use as imaging agents |
| 02/17/1993 | EP0527131A1 Chelants |